LINC00488 Induces Tumorigenicity in Retinoblastoma by Regulating microRNA-30a-5p/EPHB2 Axis

References

• Ortiz MV, Dunkel IJ. Retinoblastoma. J Child Neurol. 2016;31(2):227–236. doi:10.1177/0883073815587943.
   PubMed Web of Science ®Google Scholar
• Rodriguez-Galindo C, Orbach DB, VanderVeen D. Retinoblastoma. Pediatr Clin North Am. 2015;62(1):201–223. doi:10.1016/j.pcl.2014.09.014.
   PubMed Web of Science ®Google Scholar
• Mendoza PR, Grossniklaus HE. The biology of retinoblastoma. Prog Mol Biol Transl Sci. 2015;134:503–516.
   PubMed Web of Science ®Google Scholar
• Rao R, Honavar SG. Retinoblastoma. Indian J Pediatr. 2017;84(12):937–944. doi:10.1007/s12098-017-2395-0.
   PubMed Web of Science ®Google Scholar
• Dimaras H, Corson TW. Retinoblastoma, the visible CNS tumor: a review. J Neurosci Res. 2019;97(1):29–44. doi:10.1002/jnr.24213.
   PubMed Web of Science ®Google Scholar
• Yang M, Wei W. Long non-coding RNAs in retinoblastoma. Pathol Res Pract. 2019;215(8):152435. doi:10.1016/j.prp.2019.152435.
   PubMed Web of Science ®Google Scholar
• Hu C, Liu S, Han M, et al. Knockdown of lncRNA XIST inhibits retinoblastoma progression by modulating the miR-124/STAT3 axis. Biomed Pharmacother. 2018;107:547–554. doi:10.1016/j.biopha.2018.08.020.
   PubMed Web of Science ®Google Scholar
• Qi D, Wang M, Yu F. Knockdown of lncRNA-H19 inhibits cell viability, migration and invasion while promotes apoptosis via microRNA-143/RUNX2 axis in retinoblastoma. Biomed Pharmacother. 2019;109:798–805. doi:10.1016/j.biopha.2018.10.096.
   PubMed Web of Science ®Google Scholar
• Zhang H, Wang Z, Wu J, et al. Long noncoding RNAs predict the survival of patients with colorectal cancer as revealed by constructing an endogenous RNA network using bioinformation analysis. Cancer Med. 2019;8(3):863–873. doi:10.1002/cam4.1813.
   PubMed Web of Science ®Google Scholar
• Zhang J, Zhang X, Piao C, et al. A long non-coding RNA signature to improve prognostic prediction in clear cell renal cell carcinoma. Biomed Pharmacother. 2019;118:109079. doi:10.1016/j.biopha.2019.109079.
   PubMed Web of Science ®Google Scholar
• Gao J, Yin X, Yu X, et al. Long noncoding RNA LINC00488 functions as a ceRNA to regulate hepatocellular carcinoma cell growth and angiogenesis through miR-330-5. Dig Liver Dis. 2019;51(7):1050–1059. doi:10.1016/j.dld.2019.03.012.
   PubMedGoogle Scholar
• Du Z, Sun T, Hacisuleyman E, et al. Integrative analyses reveal a long noncoding RNA-mediated sponge regulatory network in prostate cancer. Nat Commun. 2016;7:10982. doi:10.1038/ncomms10982.
   PubMed Web of Science ®Google Scholar
• Zhu J, Zeng Y, Li W, et al. CD73/NT5E is a target of miR-30a-5p and plays an important role in the pathogenesis of non-small cell lung cancer. Mol Cancer. 2017;16(1):34. doi:10.1186/s12943-017-0591-1.
   PubMedGoogle Scholar
• Xiong J, Wei B, Ye Q, et al. MiR-30a-5p/UBE3C axis regulates breast cancer cell proliferation and migration. Biochem Biophys Res Commun. 2019;516(3):1013–1018. doi:10.1016/j.bbrc.2016.03.069.
   PubMed Web of Science ®Google Scholar
• Wu W, Zhao Y, Gao E, et al. LncRNA DLEU2 accelerates the tumorigenesis and invasion of non-small cell lung cancer by sponging miR-30a-5p. J Cell Mol Med. 2020;24(1):441–450. doi:10.1111/jcmm.14749.
   PubMed Web of Science ®Google Scholar
• Li J, Zhao L-M, Zhang C, et al. The lncRNA FEZF1-AS1 promotes the progression of colorectal cancer through regulating OTX1 and targeting miR-30a-5p. Oncol Res. 2020;28(1):51–63. doi:10.3727/096504019X15619783964700.
   PubMed Web of Science ®Google Scholar
• Martinez I, Cazalla D, Almstead LL, et al. miR-29 and miR-30 regulate B-Myb expression during cellular senescence. Proc Natl Acad Sci U S A. 2011;108(2):522–527. doi:10.1073/pnas.1017346108.
   PubMed Web of Science ®Google Scholar
• Gao Q, Liu W, Cai J, et al. EphB2 promotes cervical cancer progression by inducing epithelial-mesenchymal transition. Hum Pathol. 2014;45(2):372–381. doi:10.1016/j.humpath.2013.10.001.
   PubMed Web of Science ®Google Scholar
• Farshchian M, Nissinen L, Siljamäki E, et al. EphB2 Promotes Progression of Cutaneous Squamous Cell Carcinoma. J Invest Dermatol. 2015;135(7):1882–1892. doi:10.1038/jid.2015.104.
   PubMed Web of Science ®Google Scholar
• Khansaard W, Techasen A, Namwat N, et al. Increased EphB2 expression predicts cholangiocarcinoma metastasis. Tumour Biol. 2014;35(10):10031–10041. doi:10.1007/s13277-014-2295-0.
   PubMedGoogle Scholar
• He X, Chai P, Li F, et al. A novel LncRNA transcript, RBAT1, accelerates tumorigenesis through interacting with HNRNPL and cis-activating E2F3. Mol Cancer. 2020;19(1):115. doi:10.1186/s12943-020-01232-3.
   PubMed Web of Science ®Google Scholar
• Lu H, Zhang Z, Lu Y, et al. LncRNA NEAT1 acts as an miR-148b-3p sponge to regulate ROCK1 inhibition of retinoblastoma growth. Cancer Manag Res. 2021;13:5587–5597. doi:10.2147/CMAR.S271326.
   PubMed Web of Science ®Google Scholar
• Zhang X, Song L, Huang Y, et al. Downregulation of MST4 underlies a novel inhibitory role of MicroRNA Let-7a in the progression of retinoblastoma. Invest Ophthalmol Vis Sci. 2020;61(6):28. doi:10.1167/iovs.61.6.28.
   Web of Science ®Google Scholar
• Qin G, Tu X, Li H, et al. Long Noncoding RNA p53-Stabilizing and Activating RNA Promotes p53 Signaling by Inhibiting Heterogeneous Nuclear Ribonucleoprotein K deSUMOylation and Suppresses Hepatocellular Carcinoma. Hepatology. 2020;71(1):112–129. doi:10.1002/hep.30793.
   PubMed Web of Science ®Google Scholar
• Zhang C, Wu S. microRNA −378a-3p restrains the proliferation of retinoblastoma cells but promotes apoptosis of retinoblastoma cells via inhibition of FOXG1. Invest Ophthalmol Vis Sci. 2020;61(5):31. doi:10.1167/iovs.61.5.31.
   Web of Science ®Google Scholar
• Chen X, Zhao S, Li Q, et al. LncRNA NEAT1 knockdown inhibits retinoblastoma progression by miR-3619-5p/LASP1 axis. Front Genet. 2020;11:574145. doi:10.3389/fgene.2020.574145.
   PubMed Web of Science ®Google Scholar
• Song L, Huang Y, Zhang X, et al. Downregulation of microRNA-224-3p Hampers Retinoblastoma Progression via Activation of the Hippo-YAP Signaling Pathway by Increasing LATS2. Invest Ophthalmol Vis Sci. 2020;61(3):32. doi:10.1167/iovs.61.3.32.
   PubMed Web of Science ®Google Scholar
• Zeng Z, Gao Z-L, Zhang Z-P, et al. Downregulation of CKS1B restrains the proliferation, migration, invasion and angiogenesis of retinoblastoma cells through the MEK/ERK signaling pathway. Int J Mol Med. 2019;44(1):103–114. doi:10.3892/ijmm.2019.4183.
   PubMed Web of Science ®Google Scholar
• Wang L, Yang D, Tian R, et al. NEAT1 promotes retinoblastoma progression via modulating miR-124. J Cell Biochem. 2019;120(9):15585–15593. doi:10.1002/jcb.28825.
   PubMed Web of Science ®Google Scholar
• Gidlof O, Bader K, Celik S, et al. Inhibition of the long non-coding RNA NEAT1 protects cardiomyocytes from hypoxia in vitro via decreased pri-miRNA processing. Cell Death Dis. 2020;11(8):677. doi:10.1038/s41419-020-02854-7.
   PubMed Web of Science ®Google Scholar
• Liu Z, Huang Y, Zhang F, et al. Autophagy-related gene 7 deficiency caused by miR-154-5p overexpression suppresses the cell viability and tumorigenesis of retinoblastoma by increasing cell apoptosis. Ann Transl Med. 2020;8(21):1451. doi:10.21037/atm-20-6009.
   PubMed Web of Science ®Google Scholar
• Liu S, Yan G, Zhang J, et al. Knockdown of long noncoding RNA (lncRNA) metastasis-associated lung adenocarcinoma transcript 1 (MALAT1) inhibits proliferation, migration, and invasion and promotes apoptosis by targeting miR-124 in retinoblastoma. Oncol Res. 2018;26(4):581–591. doi:10.3727/096504017X14953948675403.
   PubMed Web of Science ®Google Scholar
• Li L, Kang L, Zhao W, et al. miR-30a-5p suppresses breast tumor growth and metastasis through inhibition of LDHA-mediated Warburg effect. Cancer Lett. 2017;400:89–98. doi:10.1016/j.canlet.2017.04.034.
   PubMed Web of Science ®Google Scholar
• Chen C, Tang J, Xu S, et al. miR-30a-5p Inhibits Proliferation and Migration of Lung Squamous Cell Carcinoma Cells by Targeting FOXD1. Biomed Res Int. 2020;2020:2547902. doi:10.1155/2020/2547902.
   PubMed Web of Science ®Google Scholar
• Liu E, Sun X, Li J, et al. miR30a5p inhibits the proliferation, migration and invasion of melanoma cells by targeting SOX4. Mol Med Rep. 2018;18(2):2492–2498. doi:10.3892/mmr.2018.9166.
   PubMed Web of Science ®Google Scholar
• Tao J, Cong H, Wang H, et al. MiR-30a-5p inhibits osteosarcoma cell proliferation and migration by targeting FOXD1. Biochem Biophys Res Commun. 2018;503(2):1092–1097. doi:10.1016/j.bbrc.2018.06.121.
   PubMed Web of Science ®Google Scholar
• Zhou L, Jia S, Ding G, et al. Down-regulation of miR-30a-5p is associated with poor prognosis and promotes chemoresistance of gemcitabine in pancreatic ductal adenocarcinoma. J Cancer. 2019;10(21):5031–5040. doi:10.7150/jca.31191.
   PubMed Web of Science ®Google Scholar
• Wang L, Zhao S, Yu M. Mechanism of low expression of miR-30a-5p on epithelial-mesenchymal transition and metastasis in ovarian cancer. DNA Cell Biol. 2019;38(4):341–351. doi:10.1089/dna.2018.4396.
   PubMed Web of Science ®Google Scholar
• Yin J, Li Z, Ye L, et al. EphB2 represents an independent prognostic marker in patients with gastric cancer and promotes tumour cell aggressiveness. J Cancer. 2020;11(10):2778–2787. doi:10.7150/jca.38098.
   PubMed Web of Science ®Google Scholar
• Qiu W, Song S, Chen W, et al. Hypoxia-induced EPHB2 promotes invasive potential of glioblastoma. Int J Clin Exp Pathol. 2019;12(2):539–548.
   PubMed Web of Science ®Google Scholar